We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The detection of YMDD mutation of hepatitis B virus by allele-specific PCR and a cross-contamination proofed device.
- Authors
Wanchuan Zhuang; Ning Sha; Chun LYU; Jiaxin Li
- Abstract
Lamivudine (LAM) is commonly used to treat Hepatitis B virus (HBV) infection, but its use frequently induces drug resistance. Therefore, rapid and correct detection of drug-resistant HBV is important for effective treatment of HBV infection. In this study, we aimed to develop a novel, simple, and user-friendly method for the detection of LAM resistant HBV. Samples were collected from 60 HBV infected patients for the analysis by allele-specific polymerase chain reaction (AS-PCR), nucleic acid detection strip (NADS) and a cross-contamination proofed device. HBV YMDD mutations were detected by AS-PCR, restriction fragment length polymorphism (RFLP) and DNA sequencing. A 91.7% concordance between all three methods was obtained. Compared to sequencing and RFLP, AS-PCR detected more samples with mutant variants and was more sensitive. This novel method had a detection limit of approximately 103copies/ml and detected a variant of only 5% of total HBV population. In conclusion, we develop a new assay which could be useful for the detection of HBV LAM resistance, especially in resource-poor settings.
- Subjects
LAMIVUDINE; POLYMERASE chain reaction; HEPATITIS B virus; MICROBIAL mutation; MEDICAL equipment; ALLELES; THERAPEUTICS
- Publication
Pakistan Journal of Pharmaceutical Sciences, 2015, Vol 28, Issue 4, p1311
- ISSN
1011-601X
- Publication type
Article